Table 2.
Estimates of therapeutic efficacy of radical cure of vivax malaria with PQ and QN or DHA-PP
| Characteristic | Result by treatment assignment |
||
|---|---|---|---|
| AS | QN+PQ | DHA-PP+PQ | |
| No. of subjects | 41 | 39 | 36 |
| No. of withdrawals | 0 | 3 | 0 |
| No. of relapses | 32 | 7 | 2 |
| Incidence density | |||
| No. of person-wk at risk | 615 | 1,613 | 1,803 |
| Incidence density (no. of incidents/person-yr) | 2.707 | 0.226 | 0.058 |
| Efficacy (%) against relapse (95% CI) | 92 (81–96) | 98 (91–99) | |
| Cumulative incidence | |||
| 12-mo cumulative incidence (%) | 80.48 | 19.44 | 5.56 |
| Efficacy against relapse (95% CI) | 75.4 (52–87) | 92.9 (72–98) | |